Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study

Long-term outcomes of delayed clozapine initiation in treatment-resistant schizophrenia: a multicenter retrospective cohort study

Abstract Background Clozapine is the only antipsychotic medication with proven efficacy against treatment-resistant schizophrenia. This multicenter retrospective cohort study aimed to evaluate the impact of a delay in clozapine initiation on long-term outcomes. Methods Patients who initiated clozapi...

Full description

Bibliographic Details
Main Authors: Masakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, Kazuhiko Gomi, Takashi Sakakibara, Shogo Hotta, Satoru Esumi, Kiyotaka Tsubouchi, Yoshihito Shimizu, Shigeki Yamada
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Psychiatry
Subjects:
Antipsychotic agents
Time-to-treatment
Hospitalization
Early medical intervention
Secondary prevention
Online Access:https://doi.org/10.1186/s12888-023-05176-y

Internet

https://doi.org/10.1186/s12888-023-05176-y

Similar Items